Sign in

CIK 0001131399

  • Large accelerated filer
Ticker
GLAXF
Exchange
NYSE, OTC
Industry
Pharmaceutical Preparations
Incorporated
United Kingdom
Entity type
Other
Phone
+44 2080475000
Business address
79 NEW OXFORD STREET, LONDON, United Kingdom, WC1A 1DG
Former names
GLAXOSMITHKLINE PLC

Securities

  • GSK GSK plc American Depositary Shares (Each representing two Ordinary Shares) NYSE
  • GLAXF Common stock OTC
  1. 4 Open-market buy 10% owner bought 245,828 shares at $3,485,841.04 ($856,917,331,181)
  2. 4 Insider Changes in Ownership
  3. 4 Open-market buy 10% owner bought 85,579 shares at $1,369,264.00 ($117,180,243,856)
  4. 3 Insider Initial Statement of Ownership
  5. 4 Open-market buy 10% owner bought 92,674 shares at $1,673,692.44 ($155,107,773,185)
  6. 4 Insider Changes in Ownership
  7. 4 Insider Changes in Ownership
  8. 4 Open-market buy 10% owner bought 832,456 shares at $12,786,524.16 ($10,644,218,756,137)
  9. 4 Insider Changes in Ownership
  10. 4 Open-market buy 10% owner bought 172,651 shares at $3,912,271.66 ($675,457,614,371)
  11. 4 Insider Changes in Ownership
  12. 3 Insider Initial Statement of Ownership
  13. 4 Open-market buy 10% owner bought 317,770 shares at $8,544,835.30 ($2,715,292,313,281)
  14. 4 Insider Changes in Ownership
  15. 3 Insider Initial Statement of Ownership
  16. 4 Insider Changes in Ownership
  17. 4 Insider Changes in Ownership
  18. 5 Insider Annual Insider Trading Report
  19. 4 Open-market buy 10% owner bought 342,229 shares at $12,850,698.95 ($4,397,881,850,960)
  20. 3 Insider Initial Statement of Ownership

Page 4 of 7 · 132 filings